Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Greenhalgh

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|May 1, 1994
Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutationsM Huber, C Scaletta, M Benathan, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1993
Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesisH Hennings, A B Glick, D A Greenhalgh, et al.
Archives of Dermatology|November 1, 1993
Transgenic models of skin diseasesJ A Rothnagel, D A Greenhalgh, X J Wang, et al.
Oncogene|July 22, 1998
Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesisX J Wang, D A Greenhalgh, A Jiang, et al.
Environmental Health Perspectives|June 1, 1991
Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesisS H Yuspa, A Kilkenny, C Cheng, et al.
Carcinogenesis|September 1, 1994
SENCAR mouse skin tumors produced by promotion alone have A to G mutations in codon 61 of the c-rasHa geneC Sutter, D A Greenhalgh, M Ueda, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibitionX J Wang, D A Greenhalgh, J R Bickenbach, et al.
The Journal of Investigative Dermatology|June 10, 1998
Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma modelB Bonnekoh, D A Greenhalgh, S H Chen, et al.
Cancer Research|November 1, 1993
Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversionD A Greenhalgh, M I Quintanilla, C C Orengo, et al.
EJNMMI Research|September 22, 2017
[<sup>18</sup>F]Fluoromisonidazole PET in rectal cancerTanuj Puri, Tessa A Greenhalgh, James M Wilson, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|May 1, 1994
Abnormal keratin 1 and 10 cytoskeleton in cultured keratinocytes from epidermolytic hyperkeratosis caused by keratin 10 mutationsM Huber, C Scaletta, M Benathan, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1993
Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesisH Hennings, A B Glick, D A Greenhalgh, et al.
Archives of Dermatology|November 1, 1993
Transgenic models of skin diseasesJ A Rothnagel, D A Greenhalgh, X J Wang, et al.
Oncogene|July 22, 1998
Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesisX J Wang, D A Greenhalgh, A Jiang, et al.
Environmental Health Perspectives|June 1, 1991
Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesisS H Yuspa, A Kilkenny, C Cheng, et al.
Carcinogenesis|September 1, 1994
SENCAR mouse skin tumors produced by promotion alone have A to G mutations in codon 61 of the c-rasHa geneC Sutter, D A Greenhalgh, M Ueda, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibitionX J Wang, D A Greenhalgh, J R Bickenbach, et al.
The Journal of Investigative Dermatology|June 10, 1998
Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma modelB Bonnekoh, D A Greenhalgh, S H Chen, et al.
Cancer Research|November 1, 1993
Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversionD A Greenhalgh, M I Quintanilla, C C Orengo, et al.
EJNMMI Research|September 22, 2017
[<sup>18</sup>F]Fluoromisonidazole PET in rectal cancerTanuj Puri, Tessa A Greenhalgh, James M Wilson, et al.
Pageof 10